Saturday, December 22, 2012 2:36:08 PM
I have thought for quite a while that if SLRC started earning NII that covered the dividend, we would see a $27 stock. I'm sure there is more to the languishing stock price than that, but now that SLRC is finally covering the dividend with NII (pre-Crystal acquisition), and has dramatically increased the portfolio size in an immediately accretive way (but I do agree Q4 may be pretty dismal with acquisition costs and presumably a much higher mgmt fee based on gross assets without a corresponding quarter of earnings from the Crystal acquisition), I think we are positioned to see some meaningful capital appreciation. I am not as courageous as you about predicting Crystal's possible contribution to NII and dividends, so am not yet willing to try to predict a new price target.
I also agree that a modest equity offering is likely in Q1, perhaps along with some intermediate term debt financing. The former to reduce the debt/equity at hopefully above NAV prices, and the latter to replenish dry powder, although at 60% debt/equity, there isn't really a compelling reason to increase equity.
GLTA.
Recent SLRC News
- SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter Ended March 31, 2024 • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- Form 40-17G - Fidelity Bond [Rule 17G-1(g)] • Edgar (US Regulatory) • 03/08/2024 05:30:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:53:22 PM
- SLR Investment Corp. Announces Quarter and Year Ended December 31, 2023 Financial Results • GlobeNewswire Inc. • 02/27/2024 09:01:00 PM
- SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System • GlobeNewswire Inc. • 02/01/2024 02:00:00 PM
- SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter and Fiscal Year Ended December 31, 2023 • GlobeNewswire Inc. • 01/08/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:04:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 09:20:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:12:10 PM
- SLR Investment Corp. Announces Quarter Ended September 30, 2023 Financial Results • GlobeNewswire Inc. • 11/07/2023 09:03:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/04/2023 08:03:56 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/04/2023 08:01:27 PM
- SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter Ended September 30, 2023 • GlobeNewswire Inc. • 09/29/2023 12:00:00 PM
- SLR Welcomes Chris York as a Partner • PR Newswire (US) • 09/18/2023 08:03:00 PM
- SLR Appoints Brad Coleman as an Operating Partner • PR Newswire (US) • 09/18/2023 08:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2023 03:00:12 PM
- SLR Investment Corp. Announces Monthly Distribution for September 2023 • GlobeNewswire Inc. • 09/05/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 08:31:03 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 08:05:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 08:15:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 08:05:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:30:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:07:38 PM
- SLR Investment Corp. Announces Quarter Ended June 30, 2023 Financial Results • GlobeNewswire Inc. • 08/08/2023 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 03:00:10 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM